# Lyell Immunopharma, Inc.: Form 8-K, filed Dec 8, 2025

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2025-12-08
- Accepted by EDGAR: Dec 8, 2025, 06:02 ET
- Period: 2025-12-07
- Accession: 0001193125-25-310469
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000119312525310469/d35459d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000119312525310469/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000119312525310469/d35459d8k.htm

Filed Dec 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-310469. Last ingested by Listed: Nov 5, 2026, 21:15 ET. No prices; not investment advice.